Why the study?
Does intensive drug therapy affect the risk of all-cause death, CHF, MI, and stroke or TIA in elderly patients (age 65+) with hypertension and type 2 diabetes?
Does intensive drug therapy affect the risk of all-cause death, CHF, MI, and stroke or TIA in elderly patients (age 65+) with hypertension and type 2 diabetes?
In elderly patients with hypertension and type 2 diabetes, intensive drug therapy is associated with a decreased risk of death but an increased risk of severe macrovascular outcomes such as CHF, MI, and stroke.
No takes yet. Share an insight, caveat, or question.
May increase macrovascular events despite lower mortality in elderly hypertensives with diabetes; leaves open confirmation by randomized trials.
Yashkin et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: